938 related articles for article (PubMed ID: 30613297)
1. P-glycoprotein-targeted photodynamic therapy boosts cancer nanomedicine by priming tumor microenvironment.
Mao C; Li F; Zhao Y; Debinski W; Ming X
Theranostics; 2018; 8(22):6274-6290. PubMed ID: 30613297
[TBL] [Abstract][Full Text] [Related]
2. P-glycoprotein targeted and near-infrared light-guided depletion of chemoresistant tumors.
Mao C; Zhao Y; Li F; Li Z; Tian S; Debinski W; Ming X
J Control Release; 2018 Sep; 286():289-300. PubMed ID: 30081143
[TBL] [Abstract][Full Text] [Related]
3. P-glycoprotein targeted photodynamic therapy of chemoresistant tumors using recombinant Fab fragment conjugates.
Mao C; Qu P; Miley MJ; Zhao Y; Li Z; Ming X
Biomater Sci; 2018 Oct; 6(11):3063-3074. PubMed ID: 30298866
[TBL] [Abstract][Full Text] [Related]
4. Di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT) overcomes multidrug resistance by a novel mechanism involving the hijacking of lysosomal P-glycoprotein (Pgp).
Jansson PJ; Yamagishi T; Arvind A; Seebacher N; Gutierrez E; Stacy A; Maleki S; Sharp D; Sahni S; Richardson DR
J Biol Chem; 2015 Apr; 290(15):9588-603. PubMed ID: 25720491
[TBL] [Abstract][Full Text] [Related]
5. Near-infrared light switching nitric oxide nanoemitter for triple-combination therapy of multidrug resistant cancer.
Wei G; Yang G; Wei B; Wang Y; Zhou S
Acta Biomater; 2019 Dec; 100():365-377. PubMed ID: 31586724
[TBL] [Abstract][Full Text] [Related]
6. A multifunctional nano-delivery system enhances the chemo-
Zhao R; Ning X; Wang M; Yu A; Wang Y
J Mater Chem B; 2021 Nov; 9(44):9174-9182. PubMed ID: 34698329
[TBL] [Abstract][Full Text] [Related]
7. Core-matched nanoassemblies for targeted co-delivery of chemotherapy and photosensitizer to treat drug-resistant cancer.
Jiang D; Xu M; Pei Y; Huang Y; Chen Y; Ma F; Lu H; Chen J
Acta Biomater; 2019 Apr; 88():406-421. PubMed ID: 30763634
[TBL] [Abstract][Full Text] [Related]
8. P-Glycoprotein-Targeted Photothermal Therapy of Drug-Resistant Cancer Cells Using Antibody-Conjugated Carbon Nanotubes.
Suo X; Eldridge BN; Zhang H; Mao C; Min Y; Sun Y; Singh R; Ming X
ACS Appl Mater Interfaces; 2018 Oct; 10(39):33464-33473. PubMed ID: 30188117
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy inhibits P-glycoprotein mediated multidrug resistance via JNK activation in human hepatocellular carcinoma using the photosensitizer pheophorbide a.
Tang PM; Zhang DM; Xuan NH; Tsui SK; Waye MM; Kong SK; Fong WP; Fung KP
Mol Cancer; 2009 Jul; 8():56. PubMed ID: 19646254
[TBL] [Abstract][Full Text] [Related]
10. Ferroptosis Promotes Photodynamic Therapy: Supramolecular Photosensitizer-Inducer Nanodrug for Enhanced Cancer Treatment.
Zhu T; Shi L; Yu C; Dong Y; Qiu F; Shen L; Qian Q; Zhou G; Zhu X
Theranostics; 2019; 9(11):3293-3307. PubMed ID: 31244955
[TBL] [Abstract][Full Text] [Related]
11. Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein.
Sikic BI; Fisher GA; Lum BL; Halsey J; Beketic-Oreskovic L; Chen G
Cancer Chemother Pharmacol; 1997; 40 Suppl():S13-9. PubMed ID: 9272128
[TBL] [Abstract][Full Text] [Related]
12. A light in multidrug resistance: photodynamic treatment of multidrug-resistant tumors.
Capella MA; Capella LS
J Biomed Sci; 2003; 10(4):361-6. PubMed ID: 12824695
[TBL] [Abstract][Full Text] [Related]
13. Anticancer efficacy of photodynamic therapy with hematoporphyrin-modified, doxorubicin-loaded nanoparticles in liver cancer.
Chang JE; Yoon IS; Sun PL; Yi E; Jheon S; Shim CK
J Photochem Photobiol B; 2014 Nov; 140():49-56. PubMed ID: 25090224
[TBL] [Abstract][Full Text] [Related]
14. Enhanced chemotherapy of cancer using pH-sensitive mesoporous silica nanoparticles to antagonize P-glycoprotein-mediated drug resistance.
Huang IP; Sun SP; Cheng SH; Lee CH; Wu CY; Yang CS; Lo LW; Lai YK
Mol Cancer Ther; 2011 May; 10(5):761-9. PubMed ID: 21411714
[TBL] [Abstract][Full Text] [Related]
15. Evidence for a constitutive, verapamil-sensitive, non-P-glycoprotein multidrug resistance phenotype in malignant glioma that is unaltered by radiochemotherapy in vivo.
Rieger L; Rieger J; Winter S; Streffer J; Esser P; Dichgans J; Meyermann R; Weller M
Acta Neuropathol; 2000 May; 99(5):555-62. PubMed ID: 10805101
[TBL] [Abstract][Full Text] [Related]
16. Tumor-targeted hybrid protein oxygen carrier to simultaneously enhance hypoxia-dampened chemotherapy and photodynamic therapy at a single dose.
Luo Z; Tian H; Liu L; Chen Z; Liang R; Chen Z; Wu Z; Ma A; Zheng M; Cai L
Theranostics; 2018; 8(13):3584-3596. PubMed ID: 30026868
[TBL] [Abstract][Full Text] [Related]
17. Multidrug resistance: molecular mechanisms and clinical relevance.
Ling V
Cancer Chemother Pharmacol; 1997; 40 Suppl():S3-8. PubMed ID: 9272126
[TBL] [Abstract][Full Text] [Related]
18. Combination of long-acting TRAIL and tumor cell-targeted photodynamic therapy as a novel strategy to overcome chemotherapeutic multidrug resistance and TRAIL resistance of colorectal cancer.
She T; Shi Q; Li Z; Feng Y; Yang H; Tao Z; Li H; Chen J; Wang S; Liang Y; Cheng J; Lu X
Theranostics; 2021; 11(9):4281-4297. PubMed ID: 33754061
[TBL] [Abstract][Full Text] [Related]
19. Synchronous delivery of oxygen and photosensitizer for alleviation of hypoxia tumor microenvironment and dramatically enhanced photodynamic therapy.
Guo X; Qu J; Zhu C; Li W; Luo L; Yang J; Yin X; Li Q; Du Y; Chen D; Qiu Y; Lou Y; You J
Drug Deliv; 2018 Nov; 25(1):585-599. PubMed ID: 29461122
[TBL] [Abstract][Full Text] [Related]
20. Dendrimer phthalocyanine-encapsulated polymeric micelle-mediated photochemical internalization extends the efficacy of photodynamic therapy and overcomes drug-resistance in vivo.
Lu HL; Syu WJ; Nishiyama N; Kataoka K; Lai PS
J Control Release; 2011 Nov; 155(3):458-64. PubMed ID: 21689700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
